Safety and efficacy of an oxycodone vaccine: Addressing some of the unique considerations posed by opioid abuse-Reference-Cited by-同舟云学术

Safety and efficacy of an oxycodone vaccine: Addressing some of the unique considerations posed by opioid abuse

Published:2017-12-01 Issue:12 Volume:12 Page:e0184876
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Raleigh M. D.^ORCID,Peterson S. J.,Laudenbach M.,Baruffaldi F.,Carroll F. I.,Comer S. D.,Navarro H. A.,Langston T. L.,Runyon S. P.,Winston S.,Pravetoni M.,Pentel P. R.

Funder

National Institute on Drug Abuse

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference52 articles.

1. New directions in nicotine vaccine design and use;PR Pentel;Adv Pharmacol,2014

2. The future potential for cocaine vaccines;FM Orson;Expert Opin Biol Ther,2014

3. Vaccines against stimulants: cocaine and MA;T Kosten;Br J Clin Pharmacol,2014

4. Biologics to Treat Substance Use Disorders: Vaccines, monoclonal antibodies, and enzymes;P Pentel,2015

5. Biologic Approaches to Treat Substance-Use Disorders;P Skolnick;Trends Pharmacol Sci,2015

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The immunological and pharmacokinetic evaluation of Lipid-PLGA hybrid nanoparticle-based oxycodone vaccines;Biomaterials;2025-02

2. Opioid vaccine clinical testing: lessons learned;Current Opinion in Psychiatry;2024-05-01

3. Vaccines as Immunotherapies for Substance Use Disorders;American Journal of Psychiatry;2024-05-01

4. Vaccines to Treat Substance Use Disorders: Current Status and Future Directions;Pharmaceutics;2024-01-08

5. The effect of chronic stress on the immunogenicity and immunoprotection of the M6-TT vaccine in female mice;Physiology & Behavior;2023-11